Abstract

AXT Inc will report its second-quarter results on July 30, 2026, Post Market; this preview summarizes consensus expectations for revenue, profitability, margins, and adjusted EPS alongside recent media and analyst commentary since January 1, 2026.

Market Forecast

Consensus for the current quarter points to revenue of 34.09 million US dollars, EBIT of 1.63 million US dollars, and adjusted EPS of 0.07, suggesting a significant year-over-year acceleration in revenue and profitability. Forecast year-over-year growth rates are 72% for revenue, 124% for EBIT, and 154% for EPS. Company-level focus remains on demand recovery in substrates and materials, with expectations for improving gross profit margin and a return to positive net margin; the main upside sensitivity is the pace of volume recovery and cost discipline. The most promising segment is substrates, projected to contribute the majority of revenue with improving utilization.

Last Quarter Review

In the previous quarter, AXT Inc delivered revenue of 26.92 million US dollars, a gross profit margin of 29.63%, GAAP net loss attributable to the parent company of 1.62 million US dollars, a net profit margin of -6.02%, and adjusted EPS of -0.01, all on a year-over-year revenue growth of 39%. The quarter featured a notable sequential improvement in profitability metrics, with quarter-on-quarter net loss narrowing by 54% alongside mix benefits. Main business performance showed the substrates segment generated 19.28 million US dollars and materials and other contributed 7.64 million US dollars, representing a combined revenue base with substrates as the leading driver.

Current Quarter Outlook

Main business momentum and margin trajectory

Market expectations indicate top-line recovery to 34.09 million US dollars with a return to positive operating profit, implying better absorption of fixed costs and a gradual normalization of gross margin from last quarter’s 29.63%. If revenue scales to the mid-30 million range, even modest price stability could lift gross profit dollars enough to push net margin closer to breakeven or slightly positive, assuming opex remains controlled. Given the -6.02% net margin last quarter, investors will focus on whether operating leverage can translate revenue growth into a meaningfully positive net result this quarter. Any evidence of pricing resilience in core substrate lines would support gross margin expansion and EPS upside versus the 0.07 forecast.

Substrates as the primary revenue engine

Substrates contributed roughly 71.61% of last quarter’s revenue at 19.28 million US dollars, and consensus implies this mix remains dominant in the current quarter’s 34.09 million US dollars outlook. The ramp in orders across end-markets that utilize compound semiconductor substrates should support higher utilization and yield stability, both key to margin progress. Execution risk centers on product mix within substrates: higher-value wafers can deliver faster gross margin lift if volumes materialize, while a heavier tilt toward lower-priced parts would limit operating leverage. Monitoring order cadence and lead times will be essential to gauge whether growth is driven by sustained demand or short-cycle restocking.

Materials and other as a swing factor

Materials and other provided 7.64 million US dollars last quarter, about 28.39% of total sales, and serve as a buffer or drag depending on the quarter’s product mix and raw-material pricing. If materials shipments align with substrate demand, this segment can contribute incremental gross profit without proportionate opex, aiding margin expansion. However, variability in materials pricing and any supply-chain constraints could compress contribution margins and weigh on consolidated profitability. Investors should look for commentary on material cost trends and any procurement efficiencies that would protect blended gross margin as volumes increase.

Analyst Opinions

Across recent commentary, the ratio of bullish to bearish views skews positive, reflecting expectations for revenue normalization and a return to operating profitability in the near term. The majority view emphasizes that sequential improvements in utilization and a healthier order pipeline in substrates can support the forecasted EPS of 0.07, while monitoring gross margin recovery as a key validation point. Analysts highlight that execution on operating expense control and stable wafer pricing are the main variables for beating the 34.09 million US dollars revenue outlook this quarter.